Manufacturer record
Bajaj Formulations Khasra No. 161: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Bajaj Formulations Khasra No. 161 (Uttarakhand) were declared Not of Standard Quality between October 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Bajaj Formulations Khasra No. 161 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Aceclofenac and Parcetamol IP) | T251733CMfg 2025-09 · Exp 2027-08 | 01. ASSAY OF ACECLOFENAC I.P. ?Less than prescribed limit.Assay | SFDTL UttarakhandState lab | Jul 2026 |
| Diabit-GM | T25F640AMfg 2025-06 · Exp 2027-05 | The sample fails in the Test for DescriptionDescription | MDTL KathuaState lab | Apr 2026 |
| Intraconazole Capsules 100 mg (ITRASEC-100) | C24I028DMfg 2024-09 · Exp 2026-08 | The sample does not conform to I.P. Addendum 2024 with respect to the Dissolution of Itraconazole.Dissolution | CDL, KolkataCDSCO lab | Oct 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.